Dinesh Vyas, MD, MS
Associate Professor of Clinical Research and Genetics
OFFICE:
San Joaquin General Hospital
Department of Surgery
500 West Hospital Road
French Camp, CA 95231
EDUCATION:
MBBS, Rajasthan University, India
MEDICAL:
Masters of Surgery, Rajasthan University, India
RESIDENCY & FELLOWSHIP:
- General Surgery, University of Pittsburgh, Pittsburgh, PA
- Case Western Reserve University, Cleveland, OH
- Research Fellow, Washington University School of Medicine, St. Louis, MO
BASIC SCIENCE LAB:
Nanomedicine, Cancer inhibitors & Inflammation/Sepsis (NIH Funded)
EDITORIAL BOARD:
- Editorial Board, Scientific Reports (Nature Journal) (2013 - Present)
- Editorial Board, Journal of OncoTargets and Therapy (2013 - Present)
- Associate Editor, Journal of Biomedical Nanotechnology (2013- Present)
- Editor-in-chief, American Journal of Robotic Surgery (2013 - Present) www.aspbs.com/ajrs
- Editor-in-chief, World Journal of Surgical Procedures (2012-15) www.wjgnet.com/2219-2832/
- Editorial Board, Journal of Laparoendoscopic and Advanced SurgTech (2010- Present)
- Editorial Board, World Journal of Gastroenterology (2010- 17)
- Editorial Board, Journal of Liver, (2011 - Present)
- Editorial Board, Reference.Medscape.com, (2011 - Present)
- Editor, Newsletter, Arogyaa.com, (October 2010)
- Editor-in-chief, First Edition, Comprehensive Textbook for Surgeons, Jaypee Publishers, (2006- 11)
- Editor-in-chief, First Responder’s Manual of Prehospital Trauma Care, Scientific Publisher (2017)
GRANTS:
- 2015 Dr. Delia Koo Global Faculty Endowment, International Studies and Program, MSU ($5000/cycle)
- 2011-13 NIH K12 Grant, Multi-functional nanomolecule in triple negative breast cancer, BIRCWH Grant, USD 100,000/yr
- 2001 Trauma Grant, Emergency care, Worst earthquake in India, INR 500,000
GLOBAl HEALTH:
Dr. Vyas contributed to training approximately 2000 first responders during his 2014 in 8 sessions using the most innovative education model with the intention of spreading the knowledge of proper emergency care.
This is the fastest growing program of its kind anywhere for first responder training and with projected growth can reduce trauma mortality by 25% in next 6-8 years. This program includes faculty from various leading institutes in the US and aboard like India.
Dr. Vyas believed that by training policemen, paramedics, firefighters, security guards and ambulance drivers, in the proper care of the injured patient before they arrive at the hospital, thousands of lives could be saved and further lifelong disabilities could be avoided.
Dr. Vyas's interview with MSU Today is available here.
PUBLICATIONS:
Aekka A., M. V. Hollis, E. M. Boudiab, G. P. Laput, H. Purohit, A. K. Vyas, Vyas D. Prehospital Trauma Care Education for First Responders in India, Journal of Surgical Research 2015 Aug;197(2):331-8
Hollis M., Nair A, Chaturvedi LS, Vyas A, Gambhir S, Vyas D. miRNA and colorectal cancer, WJG July 21, 2015, Volume 21, Issue 27
G. P. Laput, Aekka A., M. V. Hollis, E. M. Boudiab, H. Purohit, A. K. Vyas, Vyas D. Multi-institution study in Prehospital Trauma Care Education for First Responders, JACS 2015 Nov (Abstract, in press)
Vyas D.*, Sahil Gambhir*, Hollis M. Vyas A. Gastrointestinal Cancer and Nf-kB, World Journal of Gastroenterology 2015 March 21; 21(11): 3174–3183 *co first autho
Vyas D, Apoorva Aeeka, Vyas AK,: Fecal transplant policy and legislation. World Journal of Gastroenterology. 2015 Jan 7; 21(1): 6–11
Vyas D, Gandhi S, Castro P, Chaturvedi L, Lopez N, Vyas A. Iron Oxide Nanoparticle with Doxorubicin and Hyaluronic Acid potentiates the efficacy of Doxorubicin in Triple Negative Breast Cancer Cells through inflammatory pathway, JNN Volume 14, Number 1, January 2014, pp. 913-923(11)
Vyas D, Yixin Tong, Chaturvedi LS; The therapeutic effect and mechanism of a novel long-acting second-generation proteasome inhibitor (SGPI) in MDA-MB-231 TNBC cells. JACS; October 2014 Volume 219, Issue 4, Supplement, Page e176
Vyas D, Gieric Laput, Vyas AK. Chemotherapy induced inflammation may cause early metastasis. Oncotarget and therapy 2014: Jun 12; 7 1015-1023
Vyas D, Ahmed Hozain. Clinical peer review in the United States: History, legal development and subsequent abuse., World Journal of Gastroenterology, June 7; 2014 20(21):
Vyas D, Wafa Abdullah. Robotic diligent and expeditious detorsion of gastric volvulus. Videoscopy-JLAST and part B January 2014, 24
Saadeh Y, Vyas A, Vyas D. Breast cancer and theranostic nanoparticle, Journal of Nanoscience and Nanotechnology, Volume 14, Number 1, January 2014 , pp. 913-923(11)
Vyas D, Castro P, Saadeh Y, Gandhi S, Lopez N, Vyas A. Gastrointestinal diseases and theranostic Nanoparticle, Journal of Biomedical Nanotechnology, 2014
MANUSCRIPTS SUBMITTED:
Vyas D., Abraham R: Strategically leapfrogging education in prehospital management: Four-tiered training (Lancet Global Health)
Vyas D., Hollis M. Multi-institutional study of execution of prehospital care curriculum in fast developing economies: Scalable and reproducible. (Lancet Global Health)
Lopez N, Gandhi S, Castro P, Chaturvedi L, Vyas A, Vyas D. A second-generation proteasome inhibitor is more potent than Doxorubicin modulating IL-6, pSTAT-3 and NF-kB activity in triple negative breast cancer. Scientific Reports (Nature) (Respond with revision)
Vyas D., Neeti Rustagi, Abraham R: Missing piece in national trauma health policy issues in fast developing economy (Lancet Global Health)
Vyas D, Gieric L, Ching K, Chaturvedi LS, Vyas A: Rapid extensive recurrence of triple negative breast cancer: Is both therapy and cancer biology the culprit. Southern Medical Journal
Hesson A, Vyas D, Spigelian hernia post Roux-en-Y: a novel perspective on the relationship between obesity and ventral hernia, Journal of Surgery Case Reports
Vyas D, Balakrishnan A. Cell cycle interventions in gastrointestinal cancers. World Journal of Gastroenterology
Vyas D, Balakrishnan A. value of p-value. World Journal of Meta-analysis
Vyas D. Surgical Innovation and peer review; American Journal of Robotic Surgery
Vyas D, Chaturvedi LS, Vyas A: Microarray of inflammatory genes in treated MDA-MD-231 human breast cell line. JCOR
